British Biotech Takes Over Development of Gene Therapy for Rare Immune Disease
Orchard Therapeutics has licensed a gene therapy for the rare genetic disorder X-linked chronic granulomatous disease…
18/12/2017 - 2 minutes
Orchard Therapeutics has licensed a gene therapy for the rare genetic disorder X-linked chronic granulomatous disease…
Noble Généthon has teamed up with ignominious Sarepta to develop a gene therapy for the Duchenne…
Pharma would seemingly best biotech in any competition. A few CEOs explain why it left the honor…
As biopharma continues to weather a maelstrom of public scrutiny for its prices and profits,…
Selecta Biosciences and Généthon are collaborating to enable repeat dosing for gene therapies. The companies…
Gene Therapy is really the hot topic right now in the field of Biotech especially with…